Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1160 of 5804
-
Can tackling stigma help end HIV? new study tests a dual approach
Disease control OngoingThe overall goal of the Ssinga Nze study ("Ssinga Nze" means "If it were me" in Luganda, the local language) is to reduce HIV-related stigma and improve access to HIV care, including antiretroviral treatment (ART) and HIV pre-exposure prophylaxis (PrEP), as well as increase linka…
Phase: NA • Sponsor: Makerere University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for Platinum-Resistant ovarian cancer?
Disease control Recruiting nowOvarian cancer (OC) is a lethal disease. The purpose of this study is to assess the safety, pharmacokinetics and efficacy of ABBV901, alone or in combination with bevacizumab, in participants with ovarian cancer. ABBV901 is an investigational drug for the treatment of ovarian ca…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New targeted drug trial opens for patients with Hard-to-Treat neuroendocrine cancers
Disease control Recruiting nowThis Phase 1/2, multicenter, open-label, FIH study aims to evaluate the safety, tolerability, PK, and preliminary antitumor activity of CRN09682 in participants with SST2-expressing NENs and other solid tumors. The study includes a Dose Escalation Phase to determine the MTD and D…
Phase: PHASE1, PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Videogame 'ACTing Minds' tested as quick mental health boost
Symptom relief CompletedThe goal of this clinical trial is to test whether a single-session Acceptance and Commitment Therapy (ACT) videogame (ACTing Minds) improves psychological flexibility and mental health in adults who report mild to moderate depression, anxiety or stress. The main questions are wh…
Phase: NA • Sponsor: Swansea University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New hope for myasthenia crisis: early ravulizumab may speed ICU recovery
Disease control Recruiting nowMyasthenia Gravis (MG) is a rare autoimmune disease that causes muscle weakness and fatigue. It occurs when the immune system produces antibodies that block communication between nerves and muscles. In some patients, the disease can suddenly worsen and cause severe breathing prob…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Which fluid works best for severe diabetic ketoacidosis? a new trial aims to find out
Disease control Recruiting nowManagement of severe diabetic ketoacidosis is based on insulin therapy, correction of metabolic disorders and fluid resuscitation. Current recommendations recommend the first-line use of isotonic saline, whose composition is unbalanced, rich in chloride and sodium compared with p…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New shot aims to tame bleeding disorder in small trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamic (PD) of SR604 in patients with von Willebrand disease.
Phase: PHASE2 • Sponsor: Shanghai RAAS Blood Products Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New shot every 3 months could ease acromegaly treatment
Disease control Recruiting nowThe primary purpose of this study is to assess the effect of Debio 4126 in the maintenance of the levels of insulin-like growth factor 1 (IGF-1) ≤1x upper limit of normal (ULN) in the double-blind period (Period 1) in comparison to placebo at week 36.
Phase: PHASE3 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Acupuncture with electricity may help men stop leaking after prostate removal
Symptom relief Not yet recruitingThis clinical trial aims to find out if early electroacupuncture (EA) helps people recover the ability to control urination and is safe after surgery to remove the prostate gland for prostate cancer (radical prostatectomy). Participants are people aged 18 to 80 with localized pr…
Phase: NA • Sponsor: Shanghai University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Nerve zaps plus hand training could boost stroke recovery
Symptom relief Recruiting nowStroke is a leading cause of death and disability worldwide, resulting in significant physical and cognitive impairments. Arm weakness is most common after stroke and its treatment is recognized as an area of considerable need. The functional limitations and disabilities experien…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New hope for chronic hives: barzolvolimab shows promise in Long-Term trial
Disease control ENROLLING_BY_INVITATIONThe purpose of this extension study is to collect long-term efficacy and safety data on barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) who completed the treatment and follow-up periods of the Phase 3 clinical trials. This study will also fulfill the…
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Blood test may let some cancer patients skip extra immunotherapy
Disease control Recruiting nowThe researchers are doing this study to evaluate the use of circulating tumor DNA (ctDNA) testing in making treatment decisions for advanced/recurrent endometrial cancer that has a change (mutation) in the mismatch repair deficient (MMR-D) gene or microsatellite instability high …
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for lymphoma patients: targeted therapy trial launches
Disease control Recruiting nowThis study focuses on treatment-naïve marginal zone lymphoma (MZL) patients and aims to investigate the efficacy and safety of orelabrutinib combined with or without CD20 monoclonal antibody. This is a single-arm study without a control group. All subjects will receive orelabrut…
Phase: PHASE4 • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can mindfulness ease serious mental illness? new study aims to find out
Symptom relief ENROLLING_BY_INVITATIONSerious mental illness (SMI), encompassing schizophrenia-spectrum and major mood disorders, has been estimated to affect approximately 5.4% of the U.S. adult population each year. Research shows low rates of evidence-based treatment being provided to patients with SMI. This is un…
Phase: NA • Sponsor: Butler Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Heart bypass patients: which blood thinner works best to keep grafts open?
Disease control Recruiting nowThe purpose of this study is to compare the effect of prasugrel plus low-dose aspirin versus high dose aspirin alone (300mg) and versus low dose aspirin alone (75 mg) in patients with chronic coronary disease undergoing coronary artery bypass grafting.
Phase: PHASE3 • Sponsor: Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
One pill to beat worms? new drug emodepside takes on mebendazole
Disease control ENROLLING_BY_INVITATIONThis study aims to assess the efficacy and safety of emodepside compared to mebendazole in adults and adolescents infected with T. trichiura, either as single infection or co-infections with hookworm and/or A. lumbricoides.
Phase: PHASE3 • Sponsor: Swiss Tropical & Public Health Institute • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for Hard-to-Treat cancers: experimental drug BMS-986523 enters human trials
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, and efficacy of BMS-986523 alone and in combination with anti-cancer agents in participants with advanced solid malignancies
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New pacing technique may improve outcomes after heart valve procedure
Disease control Recruiting nowTranscatheter aortic valve implantation (TAVI) has rapidly expanded over the past decade as a treatment for severe aortic valve stenosis, with over 14,000 procedures performed in France in 2021. A common complication following TAVI is traumatic atrioventricular block requiring pa…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New digital program aims to tame bipolar mood swings
Disease control Not yet recruitingPEDAL is a group-based intervention for patients with bipolar disorder that builds on the traditional group psychoeducational program (GPP) by adding digital tools and specific strategies to help manage rapid fluctuations between affective states, known as affective lability. The…
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Immune cell therapy takes on stubborn muscle weakness
Disease control Not yet recruitingThis study is a single-center, prospective, nonrandom, single-arm trial.
Phase: EARLY_PHASE1 • Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC